Activation of inflammasomes in podocyte injury of mice on the high fat diet: Effects of ASC gene deletion and silencing

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 5, 2014, Pages 836-845

  Boini, Krishna M ^a   Xia, Min ^a   Abais, Justin M ^a   Li, Guangbi ^a   Pitzer, Ashley L ^a   Gehr, Todd W B ^a   Zhang, Yang ^a   Li, Pin Lan ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Asc; Glomerulosclerosis; Inflammasome; Nalp3; Obesity

Indexed keywords

ASC; GLOMERULOSCLEROSIS; INFLAMMASOME; NALP3; OBESITY;

ANIMALS; BLOTTING, WESTERN; CYTOSKELETAL PROTEINS; DIET, HIGH-FAT; GENE DELETION; GENE SILENCING; INFLAMMASOMES; MALE; MICE; MICE, KNOCKOUT; OBESITY; PODOCYTES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84894385818     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.01.033     Document Type: Article

References (59)

1. Hedley A.A., Ogden C.L., Johnson C.L., Carroll M.D., Curtin L.R., Flegal K.M. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004, 291:2847-2850.
2. Knight S.F., Imig J.D. Obesity, insulin resistance, and renal function. Microcirculation 2007, 14:349-362.
3. Ma L.J., Corsa B.A., Zhou J., Yang H., Li H., Tang Y.W., Babaev V.R., Major A.S., Linton M.F., Fazio S., Hunley T.E., Kon V., Fogo A.B. Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesity. Am. J. Physiol. Renal Physiol. 2011, 300:F1203-F1213.
4. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295:1549-1555.
5. Thakur V., Morse S., Reisin E. Functional and structural renal changes in the early stages of obesity. Contrib. Nephrol. 2006, 151:135-150.
6. Kassab S., Novak J., Miller T., Kirchner K., Granger J. Role of endothelin in mediating the attenuated renal hemodynamics in Dahl salt-sensitive hypertension. Hypertension 1997, 30:682-686.
7. Hall J.E., Henegar J.R., Dwyer T.M., Liu J., Da Silva A.A., Kuo J.J., Tallam L. Is obesity a major cause of chronic kidney disease?. Adv. Ren. Replace. Ther. 2004, 11:41-54.
8. Boini K.M., Zhang C., Xia M., Han W.Q., Brimson C., Poklis J.L., Li P.L. Visfatin-induced lipid raft redox signaling platforms and dysfunction in glomerular endothelial cells. Biochim. Biophys. Acta 2010, 1801:1294-1304.
9. Axelsson J., Heimburger O., Stenvinkel P. Adipose tissue and inflammation in chronic kidney disease. Contrib. Nephrol. 2006, 151:165-174.
10. Hunley T.E., Ma L.J., Kon V. Scope and mechanisms of obesity-related renal disease. Curr. Opin. Nephrol. Hypertens. 2010, 19:227-234.
11. Mariathasan S., Newton K., Monack D.M., Vucic D., French D.M., Lee W.P., Roose-Girma M., Erickson S., Dixit V.M. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 2004, 430:213-218.
12. Masters S.L., Latz E., O'Neill L.A. The inflammasome in atherosclerosis and type 2 diabetes. Sci. Transl. Med. 2011, 3:81. (ps17).
13. Duewell P., Kono H., Rayner K.J., Sirois C.M., Vladimer G., Bauernfeind F.G., Abela G.S., Franchi L., Nunez G., Schnurr M., Espevik T., Lien E., Fitzgerald K.A., Rock K.L., Moore K.J., Wright S.D., Hornung V., Latz E. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010, 464:1357-1361.
14. Salminen A., Ojala J., Suuronen T., Kaarniranta K., Kauppinen A. Amyloid-beta oligomers set fire to inflammasomes and induce Alzheimer's pathology. J. Cell. Mol. Med. 2008, 12:2255-2262.
15. Heneka M.T., Kummer M.P., Stutz A., Delekate A., Schwartz S., Vieira-Saecker A., Griep A., Axt D., Remus A., Tzeng T.C., Gelpi E., Halle A., Korte M., Latz E., Golenbock D.T. NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 2013, 493:674-678.
16. De Nardo D., Latz E. NLRP3 inflammasomes link inflammation and metabolic disease. Trends Immunol. 2011, 32:373-379.
17. Dostert C., Petrilli V., Van Bruggen R., Steele C., Mossman B.T., Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008, 320:674-677.
18. Horng T., Hotamisligil G.S. Linking the inflammasome to obesity-related disease. Nat. Med. 2011, 17:164-165.
19. Imaeda A.B., Watanabe A., Sohail M.A., Mahmood S., Mohamadnejad M., Sutterwala F.S., Flavell R.A., Mehal W.Z. Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J. Clin. Invest. 2009, 119:305-314.
20. Martinon F., Petrilli V., Mayor A., Tardivel A., Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006, 440:237-241.
21. Vandanmagsar B., Youm Y.H., Ravussin A., Galgani J.E., Stadler K., Mynatt R.L., Ravussin E., Stephens J.M., Dixit V.D. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 2011, 17:179-188.
22. Zhou R., Tardivel A., Thorens B., Choi I., Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 2010, 11:136-140.
23. Davis B.K., Wen H., Ting J.P. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu. Rev. Immunol. 2011, 29:707-735.
24. Faul C., Asanuma K., Yanagida-Asanuma E., Kim K., Mundel P. Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol. 2007, 17:428-437.
25. Iyer S.S., Pulskens W.P., Sadler J.J., Butter L.M., Teske G.J., Ulland T.K., Eisenbarth S.C., Florquin S., Flavell R.A., Leemans J.C., Sutterwala F.S. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:20388-20393.
26. Zhang C., Boini K.M., Xia M., Abais J.M., Li X., Liu Q., Li P.L. Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia. Hypertension 2012, 60:154-162.
27. Niemir Z.I., Stein H., Dworacki G., Mundel P., Koehl N., Koch B., Autschbach F., Andrassy K., Ritz E., Waldherr R., Otto H.F. Podocytes are the major source of IL-1 alpha and IL-1 beta in human glomerulonephritides. Kidney Int. 1997, 52:393-403.
28. Tesch G.H., Yang N., Yu H., Lan H.Y., Foti R., Chadban S.J., Atkins R.C., Nikolic-Paterson D.J. Intrinsic renal cells are the major source of interleukin-1 beta synthesis in normal and diseased rat kidney. Nephrol. Dial. Transplant. 1997, 12:1109-1115.
29. Horvath G.L., Schrum J.E., De Nardo C.M., Latz E. Intracellular sensing of microbes and danger signals by the inflammasomes. Immunol. Rev. 2011, 243:119-135.
30. Jin C., Flavell R.A. Molecular mechanism of NLRP3 inflammasome activation. J. Clin. Immunol. 2010, 30:628-631.
31. Lamkanfi M., Dixit V.M. The inflammasomes. PLoS Pathog. 2009, 5:e1000510.
32. Lamkanfi M., Walle L.V., Kanneganti T.D. Deregulated inflammasome signaling in disease. Immunol. Rev. 2011, 243:163-173.
33. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-832.
34. Shaw P.J., McDermott M.F., Kanneganti T.D. Inflammasomes and autoimmunity. Trends Mol. Med. 2011, 17:57-64.
35. Wilson S.P., Cassel S.L. Inflammasome-mediated autoinflammatory disorders. Postgrad. Med. 2010, 122:125-133.
36. Halle A., Hornung V., Petzold G.C., Stewart C.R., Monks B.G., Reinheckel T., Fitzgerald K.A., Latz E., Moore K.J., Golenbock D.T. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 2008, 9:857-865.
37. Anders H.J., Muruve D.A. The inflammasomes in kidney disease. J. Am. Soc. Nephrol. 2011, 22:1007-1018.
38. Vilaysane A., Chun J., Seamone M.E., Wang W., Chin R., Hirota S., Li Y., Clark S.A., Tschopp J., Trpkov K., Hemmelgarn B.R., Beck P.L., Muruve D.A. The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J. Am. Soc. Nephrol. 2010, 21:1732-1744.
39. Shigeoka A.A., Mueller J.L., Kambo A., Mathison J.C., King A.J., Hall W.F., da Silva Correia J., Ulevitch R.J., Hoffman H.M., McKay D.B. An inflammasome-independent role for epithelial-expressed Nlrp3 in renal ischemia-reperfusion injury. J. Immunol. 2010, 185:6277-6285.
40. Wang C., Pan Y., Zhang Q.Y., Wang F.M., Kong L.D. Quercetin and allopurinol ameliorate kidney injury in STZ-treated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation. PLoS One 2012, 7:e38285.
41. Stienstra R., van Diepen J.A., Tack C.J., Zaki M.H., van de Veerdonk F.L., Perera D., Neale G.A., Hooiveld G.J., Hijmans A., Vroegrijk I., van den Berg S., Romijn J., Rensen P.C., Joosten L.A., Netea M.G., Kanneganti T.D. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:15324-15329.
42. Deji N., Kume S., Araki S., Soumura M., Sugimoto T., Isshiki K., Chin-Kanasaki M., Sakaguchi M., Koya D., Haneda M., Kashiwagi A., Uzu T. Structural and functional changes in the kidneys of high-fat diet-induced obese mice. Am. J. Physiol. Renal Physiol. 2009, 296:F118-F126.
43. Jiang T., Wang Z., Proctor G., Moskowitz S., Liebman S.E., Rogers T., Lucia M.S., Li J., Levi M. Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J. Biol. Chem. 2005, 280:32317-32325.
44. Decleves A.E., Mathew A.V., Cunard R., Sharma K. AMPK mediates the initiation of kidney disease induced by a high-fat diet. J. Am. Soc. Nephrol. 2011, 22:1846-1855.
45. Boini K.M., Xia M., Li C., Zhang C., Payne L.P., Abais J.M., Poklis J.L., Hylemon P.B., Li P.L. Acid sphingomyelinase gene deficiency ameliorates the hyperhomocysteinemia-induced glomerular injury in mice. Am. J. Pathol. 2011, 179:2210-2219.
46. Abais J.M., Zhang C., Xia M., Liu Q., Gehr T., Boini K.M., Li P.L. NADPH oxidase-mediated triggering of inflammasome activation in mouse podocytes and glomeruli during hyperhomocysteinemia. Antioxid. Redox Signal. 2013, 18:1537-1548.
47. Boini K.M., Xia M., Xiong J., Li C., Payne L.P., Li P.L. Implication of CD38 gene in podocyte epithelial-to-mesenchymal transition and glomerular sclerosis. J. Cell. Mol. Med. 2012, 16:1674-1685.
48. Boini K.M., Zhang C., Xia M., Poklis J.L., Li P.L. Role of sphingolipid mediator ceramide in obesity and renal injury in mice fed a high-fat diet. J. Pharmacol. Exp. Ther. 2010, 334:839-846.
49. Zhang C., Xia M., Boini K.M., Li C.X., Abais J.M., Li X.X., Laperle L.A., Li P.L. Epithelial-to-mesenchymal transition in podocytes mediated by activation of NADPH oxidase in hyperhomocysteinemia. Pflugers Arch. 2011, 462:455-467.
50. De Miguel C., Lund H., Mattson D.L. High dietary protein exacerbates hypertension and renal damage in Dahl SS rats by increasing infiltrating immune cells in the kidney. Hypertension 2011, 57:269-274.
51. Stienstra R., Joosten L.A., Koenen T., van Tits B., van Diepen J.A., van den Berg S.A., Rensen P.C., Voshol P.J., Fantuzzi G., Hijmans A., Kersten S., Muller M., van den Berg W.B., van Rooijen N., Wabitsch M., Kullberg B.J., van der Meer J.W., Kanneganti T., Tack C.J., Netea M.G. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab. 2010, 12:593-605.
52. Timoshanko J.R., Kitching A.R., Iwakura Y., Holdsworth S.R., Tipping P.G. Leukocyte-derived interleukin-1beta interacts with renal interleukin-1 receptor I to promote renal tumor necrosis factor and glomerular injury in murine crescentic glomerulonephritis. Am. J. Pathol. 2004, 164:1967-1977.
53. Timoshanko J.R., Kitching A.R., Iwakura Y., Holdsworth S.R., Tipping P.G. Contributions of IL-1beta and IL-1alpha to crescentic glomerulonephritis in mice. J. Am. Soc. Nephrol. 2004, 15:910-918.
54. Silverman W.R., de Rivero Vaccari J.P., Locovei S., Qiu F., Carlsson S.K., Scemes E., Keane R.W., Dahl G. The pannexin 1 channel activates the inflammasome in neurons and astrocytes. J. Biol. Chem. 2009, 284:18143-18151.
55. Yamasaki K., Muto J., Taylor K.R., Cogen A.L., Audish D., Bertin J., Grant E.P., Coyle A.J., Misaghi A., Hoffman H.M., Gallo R.L. NLRP3/cryopyrin is necessary for interleukin-1beta (IL-1beta) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury. J. Biol. Chem. 2009, 284:12762-12771.
56. Takano Y., Yamauchi K., Hayakawa K., Hiramatsu N., Kasai A., Okamura M., Yokouchi M., Shitamura A., Yao J., Kitamura M. Transcriptional suppression of nephrin in podocytes by macrophages: roles of inflammatory cytokines and involvement of the PI3K/Akt pathway. FEBS Lett. 2007, 581:421-426.
57. Chen G.Y., Nunez G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 2010, 10:826-837.
58. Lamkanfi M. Emerging inflammasome effector mechanisms. Nat. Rev. Immunol. 2011, 11:213-220.
59. Martinon F., Burns K., Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 2002, 10:417-426.